loadpatents
name:-0.026278018951416
name:-0.026304006576538
name:-0.003018856048584
Horwitz; Marcus A. Patent Filings

Horwitz; Marcus A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Horwitz; Marcus A..The latest application filed is for "pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles".

Company Profile
2.24.23
  • Horwitz; Marcus A. - Los Angeles CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Safe potent single platform vaccine against Tier 1 select agents and other pathogens
Grant 11,224,647 - Horwitz , et al. January 18, 2
2022-01-18
Pathogen-specific cargo delivery and diagnostic platform based on mesoporous silica nanoparticles
Grant 11,045,555 - Zink , et al. June 29, 2
2021-06-29
Pathogen-specific Cargo Delivery And Diagnostic Platform Based On Mesoporous Silica Nanoparticles
App 20190321486 - Zink; Jeffrey I. ;   et al.
2019-10-24
Safe Potent Single Platform Vaccine Against Tier 1 Select Agents And Other Pathogens
App 20190240310 - HORWITZ; Marcus A. ;   et al.
2019-08-08
Live recombinant booster vaccine against tuberculosis
Grant 10,010,595 - Horwitz , et al. July 3, 2
2018-07-03
Novel Live Recombinant Booster Vaccine Against Tuberculosis
App 20150056242 - Horwitz; Marcus A. ;   et al.
2015-02-26
Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins
Grant 8,932,846 - Horwitz , et al. January 13, 2
2015-01-13
Vaccines against tularemia
Grant 8,481,024 - Horwitz , et al. July 9, 2
2013-07-09
Novel Live Recombinant Booster Vaccine Against Tuberculosis
App 20130101614 - Horwitz; Marcus A. ;   et al.
2013-04-25
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
Grant 8,383,132 - Horwitz , et al. February 26, 2
2013-02-26
Immunostimulatory recombinant intracellular pathogen immunogenic compositions and methods of use
Grant 8,287,879 - Horwitz , et al. October 16, 2
2012-10-16
Methods and compositions for treating tularemia
Grant 8,206,700 - Horwitz , et al. June 26, 2
2012-06-26
Growth regulatable recombinant BCG compositions
Grant 8,163,294 - Horwitz , et al. April 24, 2
2012-04-24
Vaccines Against Tularemia
App 20120052085 - Horwitz; Marcus A. ;   et al.
2012-03-01
Recombinant intracellular pathogen immunogenic compositions and methods of use
Grant 8,124,068 - Horwitz , et al. February 28, 2
2012-02-28
Immunostimulatory Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use
App 20110129492 - Horwitz; Marcus A. ;   et al.
2011-06-02
Growth Regulatable Recombinant Bcg Immunogenic Compositions
App 20100284963 - Horwitz; Marcus A. ;   et al.
2010-11-11
Methods And Compositions For Treating Tularemia
App 20100215679 - Horwitz; Marcus A. ;   et al.
2010-08-26
Unmarked Recombinant Intracellular Pathogen Immunogenic Compositions Expressing High Levels of Recombinant Proteins
App 20100183547 - Horwitz; Marcus A. ;   et al.
2010-07-22
Recombinant Intracellular Pathogen Immunogenic Compositions and Methods of Use
App 20100092518 - Horwitz; Marcus A. ;   et al.
2010-04-15
Recombinant intracellular pathogen immunogenic compositions and methods for use
Grant 7,622,107 - Horwitz , et al. November 24, 2
2009-11-24
Immunostimulatory Recombinant Intracellular Pathogen Immunogenic Compositions And Methods Of Use
App 20090175901 - Horwitz; Marcus A. ;   et al.
2009-07-09
Abundant extracellular products and methods for their production and use
Grant 7,300,660 - Horwitz , et al. November 27, 2
2007-11-27
Recombinant intracellular pathogen immunogenic compositions and methods for use
App 20070128216 - Horwitz; Marcus A. ;   et al.
2007-06-07
Abundant extracellular products and methods for their production and use
App 20060182754 - Horwitz; Marcus A. ;   et al.
2006-08-17
Treatment of mycobacterium tuberculosis with antisense oligonucleotides
App 20060183676 - Horwitz; Marcus A. ;   et al.
2006-08-17
Abundant extracellular products and methods for their production and use
Grant 7,002,002 - Horwitz , et al. February 21, 2
2006-02-21
Recombinant intracellular pathogen immunogenic compositions and methods for use
Grant 6,924,118 - Horwitz , et al. August 2, 2
2005-08-02
Abundant extracellular products and methods for their production and use
App 20040228873 - Horwitz, Marcus A. ;   et al.
2004-11-18
Abundant extracellular products and methods for their production and use
Grant 6,818,223 - Horwitz , et al. November 16, 2
2004-11-16
Abundant extracellular products and methods for their production and use
Grant 6,761,894 - Horwitz July 13, 2
2004-07-13
Abundant extracellular product vaccines and methods for their production and use
Grant 6,752,993 - Horwitz June 22, 2
2004-06-22
Treatment of mycobacterium tuberculosis with antisense polynucleotides
App 20040033972 - Horwitz, Marcus A. ;   et al.
2004-02-19
Abundant extracellular products and methods for their production and use
App 20040018209 - Horwitz, Marcus A. ;   et al.
2004-01-29
Recombinant intracellular pathogen immunogenic compositions and methods for use
App 20040009184 - Horwitz, Marcus A. ;   et al.
2004-01-15
Abundant extracellular products and methods for their production and use
App 20030152584 - Horwitz, Marcus A.
2003-08-14
Abundant extracellular products and methods for their production and use
Grant 6,599,510 - Horwitz , et al. July 29, 2
2003-07-29
Recombinant intracellular pathogen vaccines and methods for use
App 20030124135 - Horwitz, Marcus A. ;   et al.
2003-07-03
Recombinant intracellular pathogen vaccines and methods for use
Grant 6,471,967 - Horwitz , et al. October 29, 2
2002-10-29
Abundant extracellular products and methods for their production and use
App 20020150592 - Horwitz, Marcus A.
2002-10-17
Abundant extracellular products and methods for their production and use
App 20020131975 - Horwitz, Marcus A. ;   et al.
2002-09-19
Anti-microbial targeting for intracellular pathogens
Grant 6,054,133 - Horwitz , et al. April 25, 2
2000-04-25
Iron chelator and inhibitor of iron-mediated oxidant injury
Grant 5,721,209 - Horwitz , et al. February 24, 1
1998-02-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed